# Reversibility of Dual Antiplatelet Therapy by Platelets

> **NCT01248351** · PHASE2 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 6 (actual)

## Conditions studied

- Bleeding

## Interventions

- **OTHER:** autologous stored platelets
- **OTHER:** administration of autologous stored platelets
- **BIOLOGICAL:** autologous stored platelets

## Key facts

- **NCT ID:** NCT01248351
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-02
- **Final completion:** 2011-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248351, "Reversibility of Dual Antiplatelet Therapy by Platelets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01248351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*